- Home
- UHT vs HQL Comparison
UHT vs HQL Comparison
Compare UHT & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UHT | HQL |
|---|---|---|
| Founded | 1986 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Investment Managers |
| Sector | Real Estate | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 561.5M | 521.2M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | UHT | HQL |
|---|---|---|
| Price | $38.14 | $16.73 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 148.5K | 120.2K |
| Earning Date | 10-26-2026 | 01-01-0001 |
| Dividend Yield | 7.86% | ★ 11.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.79 | 0.79 |
| Revenue | ★ $99,190,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.23 | N/A |
| P/E Ratio | $48.34 | ★ $21.82 |
| Revenue Growth | ★ 0.18 | N/A |
| 52 Week Low | $35.69 | $15.66 |
| 52 Week High | $46.30 | $22.67 |
Technical Indicators
Market Signals| Indicator | UHT | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 45.78 | 27.65 |
| Support Level | $37.96 | $16.16 |
| Resistance Level | $42.74 | $17.47 |
| Average True Range (ATR) | 0.96 | 0.62 |
| MACD | 0.21 | -0.06 |
| Stochastic Oscillator | 70.86 | 2.39 |
Price Performance
Historical ComparisonAbout UHT Universal Health Realty Income Trust
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.